203 related articles for article (PubMed ID: 19391205)
1. Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects.
Choi CW; Kim BI; Hong JS; Kim EK; Kim HS; Choi JH
Pediatr Res; 2009 Mar; 65(3):323-7. PubMed ID: 19391205
[TBL] [Abstract][Full Text] [Related]
2. Association of increased pulmonary interleukin-6 with the priming effect of intra-amniotic lipopolysaccharide on hyperoxic lung injury in a rat model of bronchopulmonary dysplasia.
Kim DH; Choi CW; Kim EK; Kim HS; Kim BI; Choi JH; Lee MJ; Yang EG
Neonatology; 2010 Jun; 98(1):23-32. PubMed ID: 19955834
[TBL] [Abstract][Full Text] [Related]
3. [Effect of intra-amniotic endotoxin priming plus hyperoxic exposure on the expression of vascular endothelial growth factor and its receptors in lungs of preterm newborn rats].
Wang W; Wei W; Ning Q; Luo XP
Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):533-8. PubMed ID: 17953812
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in fetal lambs exposed to intra-amniotic endotoxin in a chorioamnionitis model.
Cheah FC; Jobe AH; Moss TJ; Newnham JP; Kallapur SG
Pediatr Res; 2008 Mar; 63(3):274-9. PubMed ID: 18091343
[TBL] [Abstract][Full Text] [Related]
5. [Increased apoptosis after intra-amniotic endotoxin priming plus hyperoxic exposure in lungs of preterm newborn rats].
Wang W; Yu X; Ning Q; Luo XP
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):767-73. PubMed ID: 20021812
[TBL] [Abstract][Full Text] [Related]
6. Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia.
Lee HJ; Choi CW; Kim BI; Kim EK; Kim HS; Choi JH; Lee MJ; Yang EG
J Perinat Med; 2010 Nov; 38(6):675-81. PubMed ID: 20707615
[TBL] [Abstract][Full Text] [Related]
7. A rat model for arrest of alveolarization induced by antenatal endotoxin administration.
Ueda K; Cho K; Matsuda T; Okajima S; Uchida M; Kobayashi Y; Minakami H; Kobayashi K
Pediatr Res; 2006 Mar; 59(3):396-400. PubMed ID: 16492978
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats.
Choi CW; Lee J; Oh JY; Lee SH; Lee HJ; Kim BI
Pediatr Res; 2016 Feb; 79(2):287-94. PubMed ID: 26551413
[TBL] [Abstract][Full Text] [Related]
9. A novel mouse model of Ureaplasma-induced perinatal inflammation: effects on lung and brain injury.
Normann E; Lacaze-Masmonteil T; Eaton F; Schwendimann L; Gressens P; Thébaud B
Pediatr Res; 2009 Apr; 65(4):430-6. PubMed ID: 19127208
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced chorioamnionitis is confined to one amniotic compartment in twin pregnant sheep.
Gantert M; Jellema RK; Heineman H; Gantert J; Collins JJ; Seehase M; Lambermont VA; Keck A; Garnier Y; Zimmermann LJ; Kadyrov M; Gavilanes AW; Kramer BW
Neonatology; 2012; 102(2):81-8. PubMed ID: 22614058
[TBL] [Abstract][Full Text] [Related]
11. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.
Velten M; Heyob KM; Rogers LK; Welty SE
J Appl Physiol (1985); 2010 May; 108(5):1347-56. PubMed ID: 20223995
[TBL] [Abstract][Full Text] [Related]
12. Intra-amniotic LPS amplifies hyperoxia-induced airway hyperreactivity in neonatal rats.
Choi CW; Kim BI; Mason SN; Potts-Kant EN; Brahmajothi MV; Auten RL
Pediatr Res; 2013 Jul; 74(1):11-8. PubMed ID: 23563192
[TBL] [Abstract][Full Text] [Related]
13. [Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease].
Chen N; Li JJ; Xue XD
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):591-4. PubMed ID: 18082049
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of maternal inflammation and neonatal hyperoxia on lung fibrosis and RAGE expression in newborn rats.
Su CL; Chou HC; Huang LT; Yeh TF; Chen CM
Pediatr Res; 2014 Feb; 75(2):273-80. PubMed ID: 24226635
[TBL] [Abstract][Full Text] [Related]
15. [Lipopolysaccharide and hyperoxia induce nuclear factor-kappa B expression in human embryo lung fibroblasts in vitro].
Zhang XT; Liu J; Yu X; Ning Q; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):661-4. PubMed ID: 18947494
[TBL] [Abstract][Full Text] [Related]
16. Activation of Akt protects alveoli from neonatal oxygen-induced lung injury.
Alphonse RS; Vadivel A; Coltan L; Eaton F; Barr AJ; Dyck JR; Thébaud B
Am J Respir Cell Mol Biol; 2011 Feb; 44(2):146-54. PubMed ID: 20348209
[TBL] [Abstract][Full Text] [Related]
17. Arginyl-glutamine dipeptide or docosahexaenoic acid attenuate hyperoxia-induced lung injury in neonatal mice.
Ma L; Li N; Liu X; Shaw L; Li Calzi S; Grant MB; Neu J
Nutrition; 2012; 28(11-12):1186-91. PubMed ID: 23044165
[TBL] [Abstract][Full Text] [Related]
18. The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
Qu S; Shan L; Chen X; Zhang Z; Wu Y; Chen Y; Zhuo F; Wang Y; Dong H
BMC Pulm Med; 2023 Jun; 23(1):209. PubMed ID: 37322452
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline and prevention of hyperoxia-induced lung -injury in neonatal rats.
Almario B; Wu S; Peng J; Alapati D; Chen S; Sosenko IR
Pediatr Res; 2012 May; 71(5):583-9. PubMed ID: 22322387
[TBL] [Abstract][Full Text] [Related]
20. Maternal PUFA ω-3 Supplementation Prevents Neonatal Lung Injuries Induced by Hyperoxia in Newborn Rats.
Sharma D; Nkembi AS; Aubry E; Houeijeh A; Butruille L; Houfflin-Debarge V; Besson R; Deruelle P; Storme L
Int J Mol Sci; 2015 Sep; 16(9):22081-93. PubMed ID: 26389878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]